ATAI Life Sciences
Price & Volume
Stats
See more52W Range | $1.15-$6.75 |
Market Cap | $1.3B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $3M |
Revenue Growth (YoY) | 1,772.5% |
Gross Profit (12 Mos) | $2.5M |
Diluted EPS | -$0.83 |
News
See moreYahoo Finance • 13 days ago
AtaiBeckley Completes Redomiciliation to the United States
Yahoo Finance • 21 days ago
Coty downgraded, Spruce Biosciences initiated: Wall Street's top analyst calls
Yahoo Finance • 21 days ago
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
Yahoo Finance • 2 months ago
H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion
About
CEO | Dr. Srinivas G. Rao M.D., Ph.D. |
Address | 250 West 34th Street, New York, NY, United States, 10119 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 54 |
